Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03829566 Background | Nov 2019 → Jan 2025 | neuromyelitis optica | Northwestern University | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03829566 ↗ |
| Action | Activate | “stimulates the bone marrow to produce granulocytes and stem cells” NCT03829566 ↗ |
| Modality | Protein / enzyme biologic | “A glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream” NCT03829566 ↗ |